Research programs designed for cost-benefit and economic issues relating to clinical use of drugs and devices, and therapeutic or treatment approaches. Quality-of-life research, therapeutic outcomes, evidence based medicine.

 

Within the framework of our CRO services, and available to every clinical development program we design and manage, we touch upon the pharmacoeconomic and health economic components.  At various stages in the development cycle, a program can potentially benefit from a proper review of outcomes analysis.

 

Working with device manufacturers, pharmaceutical companies, healthcare companies, we design and manage a variety of outcomes programs, including global trials, and registry studies.  Using modern available resources, today, conduting far-reaching post marketing studies offering unprecedented cost-effectiveness data is within every programs reach.  Outcomes Data, Quality of Life Studies, Patient Subpopulation Studies, Postmarketing Surveillance of Medical Devices, Reimbursement Models.